| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |